Genetic Defects in Early-Onset Inflammatory Bowel Disease

Area of Science:

• Immunology
• Genetics
• Gastroenterology

Background:

• Inflammatory bowel disease (IBD) is a group of chronic gastrointestinal inflammatory conditions.
• Monogenic mutations are more prevalent in early-onset IBD compared to adult-onset IBD.
• These mutations affect both innate and adaptive immune responses.

Purpose of the Study:

• To highlight the role of monogenic mutations in IBD pathogenesis.
• To emphasize the impact on innate and adaptive immunity.
• To underscore the potential for precision medicine in IBD.

Main Methods:

• Review of genetic and immunological studies in IBD.
• Analysis of pathogenic gene functions in immune dysregulation.
• Exploration of advanced genomic and functional testing.

Main Results:

• Monogenic mutations are key drivers of IBD, especially in early-onset disease.
• Dysregulated immune responses involve intestinal barrier, phagocytes, T cells, and B cells.
• Genomic and functional testing can identify specific genetic defects.

Conclusions:

• Understanding monogenic IBD provides insights into immune system regulation.
• Precision medicine approaches tailored to genetic profiles can improve IBD management.
• Advanced diagnostics are crucial for optimizing clinical decision-making in IBD.